Antoni van Leeuwenhoek
Amsterdam, Netherlands
24 recruiting
Showing 1–20 of 30 trials
Recruiting
Phase 2
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small Cell Lung
Johnson & Johnson Enterprise Innovation Inc.130 enrolled40 locationsNCT06667908
Recruiting
Phase 3
NO Re-excision MelanomA - NORMA 2
Melanoma (Skin Cancer)
Marieke Goodijk1,749 enrolled21 locationsNCT07530887
Recruiting
Phase 3
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Janssen Research & Development, LLC1,000 enrolled234 locationsNCT06662786
Recruiting
Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study
Gastrointenstinal Stromal Tumor (GIST)
The Netherlands Cancer Institute330 enrolled1 locationNCT07522762
Recruiting
Phase 3
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Janssen Research & Development, LLC700 enrolled234 locationsNCT06750094
Recruiting
Phase 3
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
AVEO Pharmaceuticals, Inc.410 enrolled112 locationsNCT06064877
Recruiting
Not Applicable
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Ovarian CancerBRCA1 Gene MutationBRCA2 Gene Mutation+3 more
University Medical Center Nijmegen3,000 enrolled66 locationsNCT04294927
Recruiting
Phase 3
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Gastric CancerGastroesophageal-junction Cancer
Daiichi Sankyo726 enrolled250 locationsNCT06731478
Recruiting
Phase 3
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Non-small Cell Lung CancerNSCLCNSCLC (Advanced Non-small Cell Lung Cancer)+2 more
Revolution Medicines, Inc.420 enrolled129 locationsNCT06881784
Recruiting
Phase 1Phase 2
Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers
CancerHLA-A*02:01-positive
Immunocore Ltd600 enrolled13 locationsNCT06840119
Recruiting
Phase 3
Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer
Prostate Cancer
Nick Beije400 enrolled26 locationsNCT07260435
Recruiting
Phase 3
Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial
Cisplatin-related Hearing Loss
The Netherlands Cancer Institute100 enrolled5 locationsNCT07281508
Recruiting
Phase 2
Basket Study for Oligo-metastatic Breast Cancer
HER2-positive Breast Cancer
The Netherlands Cancer Institute72 enrolled1 locationNCT05982678
Recruiting
Not Applicable
Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients
Breast Cancer
The Netherlands Cancer Institute100 enrolled1 locationNCT06273800
Recruiting
Not Applicable
Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer
Stomach Neoplasm
Amsterdam UMC654 enrolled16 locationsNCT05180864
Recruiting
Functional Liver After SBRT
Liver Metastases
The Netherlands Cancer Institute15 enrolled1 locationNCT07033364
Recruiting
OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes
Breast Cancer Stage ITriple Negative Breast Cancer(TNBC)
The Netherlands Cancer Institute490 enrolled28 locationsNCT06476119
Recruiting
Not Applicable
DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy
Breast Cancer
The Netherlands Cancer Institute595 enrolled1 locationNCT05416164
Recruiting
Prospective Data Collection Initiative on Colorectal Cancer
Colorectal, Cancer
Dutch Colorectal Cancer Group50,000 enrolled67 locationsNCT02070146
Recruiting
Phase 1Phase 2
FMT to Convert Response to Immunotherapy
Melanoma Stage IVMelanoma Stage III
The Netherlands Cancer Institute24 enrolled1 locationNCT05251389